| Compound name | Brutto | MW | CAS | PubChem CID | Action | Reference | Reference |
|---|---|---|---|---|---|---|---|
| Harmane | C12H10N2 | 182.22 | 486-84-0 | 5281404 | serotonin, monoamine oxidase | Smith KL. (2013) J Psychopharmacol. 162-70 |
| Kinase | % Activity Remaining Sort descending | Standard Deviation |
|---|---|---|
| DYRK1A | 44 | 3 |
| ERK8 | 69 | 0 |
| DYRK3 | 72 | 3 |
| p38 alpha MAPK | 74 | 1 |
| IKK beta | 76 | 8 |
| NEK2a | 78 | 0 |
| PLK1 | 80 | 2 |
| PIM3 | 80 | 0 |
| SRPK1 | 80 | 2 |
| MST2 | 80 | 1 |
| CSK | 81 | 5 |
| MNK1 | 82 | 1 |
| MELK | 82 | 2 |
| DYRK2 | 83 | 5 |
| Src | 83 | 2 |
| PRAK | 84 | 8 |
| CK2 | 84 | 7 |
| JNK2 | 84 | 5 |
| PRK2 | 84 | 5 |
| PIM2 | 85 | 1 |
| CAMKK alpha | 85 | 5 |
| Aurora C | 86 | 2 |
| SGK1 | 86 | 4 |
| PKD1 | 87 | 1 |
| p38 delta MAPK | 89 | 1 |
| PDK1 | 89 | 7 |
| JNK3 | 89 | 2 |
| PKC zeta | 89 | 2 |
| p38 beta MAPK | 90 | 7 |
| MSK1 | 90 | 11 |
| MKK1 | 90 | 5 |
| CAMK1 | 90 | 3 |
| NEK6 | 90 | 1 |
| PKC alpha | 90 | 5 |
| PKB beta | 91 | 7 |
| CHK2 | 91 | 3 |
| CAMKK beta | 92 | 4 |
| JNK1 | 92 | 3 |
| PIM1 | 93 | 1 |
| Lck | 93 | 1 |
| RSK2 | 94 | 1 |
| S6K1 | 94 | 3 |
| PKA | 94 | 2 |
| ERK2 | 95 | 6 |
| p38 gamma MAPK | 96 | 9 |
| PAK5 | 97 | 8 |
| RSK1 | 98 | 0 |
| CK1 delta | 98 | 6 |
| CHK1 | 98 | 3 |
| BRSK2 | 100 | 1 |
| EF2K | 100 | 3 |
| SmMLCK | 100 | 3 |
| PHK | 102 | 3 |
| CDK2-Cyclin A | 102 | 6 |
| MAPKAP-K3 | 103 | 6 |
| PKB alpha | 103 | 2 |
| PAK4 | 103 | 5 |
| HIPK2 | 104 | 5 |
| HIPK3 | 104 | 0 |
| PAK6 | 104 | 3 |
| ROCK 2 | 104 | 1 |
| NEK7 | 104 | 0 |
| Aurora B | 105 | 2 |
| ERK1 | 106 | 0 |
| GSK3 beta | 108 | 1 |
| MAPKAP-K2 | 109 | 3 |
| MNK2 | 111 | 4 |
| AMPK | 111 | 12 |
| MARK3 | 128 | 3 |